INFRAFRONTIER
Infrafrontier The European infrastructure for phenotyping and archiving of model mammalian genomes
| Coordinatore | HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Organization address
address: Ingolstaedter Landstrasse 1 contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Totale costo | 6˙091˙090 € |
| EC contributo | 4˙500˙000 € |
| Programma | FP7-INFRASTRUCTURES
Specific Programme "Capacities": Research infrastructures |
| Code Call | FP7-INFRASTRUCTURES-2007-1 |
| Funding Scheme | CP-CSA-Infra |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-03-01 - 2012-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Organization address
address: Ingolstaedter Landstrasse 1 contact info |
DE (MUENCHEN) | coordinator | 0.00 |
| 2 |
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Organization address
address: CALLE SERRANO 117 contact info |
ES (MADRID) | participant | 0.00 |
| 3 |
BIOCEV z.s.p.o.
Organization address
address: K vyzkumnym ustavum 1/1083 contact info |
CZ (PRAHA) | participant | 0.00 |
| 4 |
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING
Organization address
address: Al. Fleming Street 34 contact info |
EL (VARI-ATHENS) | participant | 0.00 |
| 5 |
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG
Organization address
address: Heinemannstrasse 2 contact info |
DE (BONN) | participant | 0.00 |
| 6 |
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE
Organization address
address: Rue Laurent Fries 1 contact info |
FR (ILLKIRCH GRAFFENSTADEN) | participant | 0.00 |
| 7 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Organization address
address: Rue Michel -Ange 3 contact info |
FR (PARIS) | participant | 0.00 |
| 8 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | participant | 0.00 |
| 9 |
DEPARTAMENT DE SALUT - GENERALITAT DE CATALUNYA
Organization address
city: BARCELONA contact info |
ES (BARCELONA) | participant | 0.00 |
| 10 |
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Organization address
address: Meyerhofstrasse 1 contact info |
DE (HEIDELBERG) | participant | 0.00 |
| 11 |
FUNDACAO CALOUSTE GULBENKIAN
Organization address
address: AVENIDA DE BERNA 45A contact info |
PT (LISBOA) | participant | 0.00 |
| 12 |
FUNDACION PARA EL CONOCIMIENTO MADRIMASD
Organization address
address: "Velazquez, bajo izquierda 76" contact info |
ES (MADRID) | participant | 0.00 |
| 13 |
FUNDACION PARQUE CIENTIFICO DE MADRID-FPCM
Organization address
address: CALLE FARADAY 7 EDIFICIO CLAID contact info |
ES (MADRID) | participant | 0.00 |
| 14 |
GENIKI GRAMMATIA EREVNAS KAI TECHNOLOGIAS
Organization address
address: Mesogeion Avenue 14-18 contact info |
EL (ATHENS) | participant | 0.00 |
| 15 |
GENOME RESEARCH LIMITED
Organization address
address: THE GIBBS BUILDING, EUSTON ROAD 215 contact info |
UK (LONDON) | participant | 0.00 |
| 16 |
HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH
Organization address
address: Inhoffenstrasse 7 contact info |
DE (BRAUNSCHWEIG) | participant | 0.00 |
| 17 |
HERMANN VON HELMHOLTZ-GEMEINSCHAFT DEUTSCHER FORSCHUNGSZENTRUM EV
Organization address
address: Ahrstrasse 45 contact info |
DE (BONN) | participant | 0.00 |
| 18 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 0.00 |
| 19 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 0.00 |
| 20 | KOBENHAVNS UNIVERSITET | DK | participant | 0.00 |
| 21 |
MEDICAL RESEARCH COUNCIL
Organization address
address: NORTH STAR AVENUE POLARIS HOUSE contact info |
UK (SWINDON) | participant | 0.00 |
| 22 |
MINISTERO DELLA SALUTE
Organization address
address: Via Giorgio Ribotta 5 contact info |
IT (ROMA) | participant | 0.00 |
| 23 |
MINISTERSTVO SKOLSTVI MLADEZE A TELOVYCHOVY
Organization address
address: Karmelitska 7 contact info |
CZ (PRAGUE) | participant | 0.00 |
| 24 |
OULUN YLIOPISTO
Organization address
address: Pentti Kaiteran Katu 1 contact info |
FI (OULU) | participant | 0.00 |
| 25 |
Toronto Centre for Phenogenomics Inc.
Organization address
address: Orde Street 25 contact info |
CA (Toronto) | participant | 0.00 |
| 26 |
UNIVERSITAT AUTONOMA DE BARCELONA
Organization address
address: Campus UAB -BELLATERRA- s/n contact info |
ES (CERDANYOLA DEL VALLES) | participant | 0.00 |
| 27 |
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE
Organization address
address: VIDENSKA 1083 contact info |
CZ (PRAHA 4) | participant | 0.00 |
| 28 |
VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL
Organization address
address: VASTRA JARNVAGSGATAN 3 contact info |
SE (STOCKHOLM) | participant | 0.00 |
| 29 |
VETERINAERMEDIZINISCHE UNIVERSITAET WIEN
Organization address
address: Veterinaerplatz 1 contact info |
AT (VIENNA) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Medically related Life Sciences use the mouse as a model system to understand the molecular basis of health and disease in humans (>95% similarity of genes in humans and mice). An essential task for Biomedical Sciences in the 21st century will be the functional analysis of mouse models for every gene in the mammalian genome. The major bottlenecks identified by the user community will be proper characterization (Mouse Clinics), archiving and dissemination of mouse disease models to the research laboratories. The current capacities, governance structures and funding strategies of existing infrastructures will not be able to serve the upcoming urgent needs. Thus it is imperative to organise and establish now an efficient distributed infrastructure for the phenotyping, archiving and dissemination of mouse models on a well concerted, large-scale and pan-European level. This will be a prerequisite for maintaining Europe’s leading role in the functional annotation of the mouse genome. Infrafrontier will guarantee the accessibility of mouse models and will be essential to facilitate their exploitation. Infrafrontier integrates 15 European laboratories with exceptional track records to implement and run large-scale infrastructures. Infrafrontier builds on existing infrastructures under EMMA and EUMODIC and forms a coalition with a significant number of funding agencies to develop the prerequisites to a common European infrastructure. The Infrafrontier preparatory phase aims to organise a stable and sustainable infrastructure by 1) the identification of the most suitable legal form, 2) developing a business plan based on a sustainable funding concept, 3) reaching a legal agreement between all partners and 4) providing a strategic plan for the construction phase. Infrafrontier will therefore give Europe a leading position in the worldwide competition on resources and knowledge for medically relevant mouse models by providing a user-driven platform.'